D Ronen

509 total citations
16 papers, 458 citations indexed

About

D Ronen is a scholar working on Molecular Biology, Virology and Infectious Diseases. According to data from OpenAlex, D Ronen has authored 16 papers receiving a total of 458 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Virology and 4 papers in Infectious Diseases. Recurrent topics in D Ronen's work include HIV Research and Treatment (5 papers), Cancer-related Molecular Pathways (4 papers) and HIV/AIDS drug development and treatment (4 papers). D Ronen is often cited by papers focused on HIV Research and Treatment (5 papers), Cancer-related Molecular Pathways (4 papers) and HIV/AIDS drug development and treatment (4 papers). D Ronen collaborates with scholars based in Israel, Hungary and United States. D Ronen's co-authors include Yael Teitz, Varda Rotter, David Reisman, Naomi Goldfinger, John L. Riggs, Doron Lancet, A. Romano, Dov Schwartz, E Eylan and Umberto Pace and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

D Ronen

16 papers receiving 440 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
D Ronen Israel	14	172	160	92	67	47	16	458
John Malinowski United States	7	367 2.1×	71 0.4×	70 0.8×	64 1.0×	54 1.1×	9	531
James J. Greene United States	15	378 2.2×	51 0.3×	27 0.3×	65 1.0×	122 2.6×	32	691
Gisele Tavares United States	9	254 1.5×	133 0.8×	58 0.6×	8 0.1×	34 0.7×	11	601
Peter Hermentin Germany	14	377 2.2×	39 0.2×	173 1.9×	62 0.9×	127 2.7×	39	630
Praveen K. Madala Australia	9	328 1.9×	70 0.4×	75 0.8×	111 1.7×	264 5.6×	14	728
Tarikere Gururaja United States	14	390 2.3×	80 0.5×	83 0.9×	17 0.3×	64 1.4×	33	595
G. F. Rowland United Kingdom	17	257 1.5×	250 1.6×	58 0.6×	62 0.9×	204 4.3×	31	799
Jowita Mikolajczyk United States	14	610 3.5×	256 1.6×	80 0.9×	41 0.6×	67 1.4×	16	808
Mohinder S. Kang United States	12	336 2.0×	37 0.2×	234 2.5×	32 0.5×	67 1.4×	18	782
Lorenz Chatwell Germany	9	235 1.4×	41 0.3×	24 0.3×	33 0.5×	81 1.7×	9	372

Countries citing papers authored by D Ronen

Since Specialization

Citations

This map shows the geographic impact of D Ronen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D Ronen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D Ronen more than expected).

Fields of papers citing papers by D Ronen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D Ronen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D Ronen. The network helps show where D Ronen may publish in the future.

Co-authorship network of co-authors of D Ronen

This figure shows the co-authorship network connecting the top 25 collaborators of D Ronen. A scholar is included among the top collaborators of D Ronen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D Ronen. D Ronen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Ronen, D, Rom T. Altstock, Leonid Mittelman, et al.. (1999). Met-HGF/SF mediates growth arrest and differentiation in T47D breast cancer cells.. PubMed. 10(2). 131–40. 27 indexed citations

Rotter, Varda & D Ronen. (1997). Expression of p53 in differentiation and apoptosis and its deregulation in tumor cell.. PubMed. 11 Suppl 3. 327–30. 2 indexed citations

Ronen, D, et al.. (1996). Induction of HL-60 cells to undergo apoptosis is determined by high levels of wild-type p53 protein whereas differentiation of the cells is mediated by lower p53 levels.. PubMed. 7(1). 21–30. 61 indexed citations

Wolkowicz, Roland, N. Barry Elkind, D Ronen, & Varda Rotter. (1995). The DNA binding activity of wild type p53 is modulated by blocking its various antigenic epitopes.. PubMed. 10(6). 1167–74. 18 indexed citations

Teitz, Yael, et al.. (1994). Inhibition of human immunodeficiency virus by N-methylisatin-β4′:4′-diethylthiosemicarbazone and N-allylisatin-β-4′:4′-diallythiosemicarbazone. Antiviral Research. 24(4). 305–314. 69 indexed citations

Teitz, Yael, et al.. (1994). Relationships between Structure and Antiretroviral Activity of Thiosemicarbazone Derivatives. Chemotherapy. 40(3). 195–200. 29 indexed citations

Teitz, Yael, et al.. (1994). Inhibition of Feline Immunodeficiency Virus Production and HIV Tat Activity by Thiosemicarbazone Derivatives. Antiviral chemistry & chemotherapy. 5(4). 229–235. 2 indexed citations

Berke, Gideon, D Rosen, & D Ronen. (1993). Mechanism of lymphocyte-mediated cytolysis: functional cytolytic T cells lacking perforin and granzymes.. PubMed. 78(1). 105–12. 30 indexed citations

Ronen, D, Yael Teitz, Naomi Goldfinger, & Varda Rotter. (1992). Expression of wild-type and mutant p53 proteins by recombinant vaccinia viruses. Nucleic Acids Research. 20(13). 3435–3441. 13 indexed citations

10.

Ronen, D, Varda Rotter, & David Reisman. (1991). Expression from the murine p53 promoter is mediated by factor binding to a downstream helix-loop-helix recognition motif.. Proceedings of the National Academy of Sciences. 88(10). 4128–4132. 56 indexed citations

11.

Ronen, D, Levana Sherman, Shoshana Bar‐Nun, & Yael Teitz. (1987). N-methylisatin-beta-4',4'-diethylthiosemicarbazone, an inhibitor of Moloney leukemia virus protein production: characterization and in vitro translation of viral mRNA. Antimicrobial Agents and Chemotherapy. 31(11). 1798–1802. 19 indexed citations

12.

Pace, Umberto, et al.. (1986). Polypeptide gp95. A unique glycoprotein of olfactory cilia with transmembrane receptor properties.. Journal of Biological Chemistry. 261(3). 1299–1305. 49 indexed citations

13.

Ronen, D, et al.. (1985). Effect of N-methylisatin-β-4′:4′-diethylthiosemicarbazone on intracellular Moloney leukemia virus constituents. Antiviral Research. 5(4). 249–254. 14 indexed citations

14.

Ronen, D & Yael Teitz. (1984). Inhibition of the synthesis of Moloney leukemia virus structural proteins by N-methylisatin-beta-4',4'-diethylthiosemicarbazone. Antimicrobial Agents and Chemotherapy. 26(6). 913–916. 16 indexed citations

15.

Eylan, E, et al.. (1977). Lysozyme tear level in patients with herpes simplex virus eye infection.. PubMed. 16(9). 850–3. 25 indexed citations

16.

Ronen, D, et al.. (1975). A spectrophotometric method for quantitative determination of lysozyme in human tears: description and evaluation of the method and screening of 60 healthy subjects.. PubMed. 14(6). 479–84. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact